Next Science TM
16
3
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
43.8%
7 terminated/withdrawn out of 16 trials
46.2%
-40.4% vs industry average
6%
1 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Post-incision Antimicrobial Wash vs C. Acnes in Shoulder Arthroplasty
Role: collaborator
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
Role: collaborator
Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications
Role: collaborator
A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne
Role: lead
Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)
Role: lead
4-Day Primary Irritation Patch Test of MIS Solution
Role: lead
Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures
Role: lead
Evaluating Wound Healing With Next Science Gel & Wash.
Role: lead
Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC
Role: lead
Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds
Role: collaborator
Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy
Role: collaborator
The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds
Role: collaborator
Initial Assessment of a Topical Cadexomer Iodine Gel Efficacy on Keloid Scar Revision
Role: lead
Safety and Efficacy of Next Science Gel on Toenail Fungus
Role: lead
Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.
Role: lead
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
Role: lead
All 16 trials loaded